C. Schäfer

发表

Guideline on management of suspected adverse reactions to ingested histamine

T. Zuberbier, L. Klimek, M. Worm, 2021, Allergologie select.

Increased Absorption of Digoxin from the Human Jejunum Due to Inhibition of Intestinal Transporter-Mediated Efflux

U. Hofmann, H. Glaeser, M. Fromm, 2007, Clinical pharmacokinetics.

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

C. Bode, T. Schütz, A. Parlesak, 2000, Journal of hepatology.

Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease.

C. Bode, A. Parlesak, C. Schäfer, 2006, Alcohol.

Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature.

J. Bode, J. Zundler, C. Schäfer, 2000, European journal of gastroenterology & hepatology.

Influence of the menstrual cycle on the LPS-induced cytokine response of monocytes.

C. Bode, J. Bode, C. Schäfer, 2000, Cytokine.

IgA Against Gut-Derived Endotoxins: Does It Contribute to Suppression of Hepatic Inflammation in Alcohol-Induced Liver Disease?

C. Bode, A. Parlesak, C. Schäfer, 2002, Digestive Diseases and Sciences.

Efficacy of double-balloon enteroscopy in the evaluation and treatment of bleeding and non-bleeding small bowel disease.

E. Stange, H. Kreichgauer, C. Schäfer, 2007, Zeitschrift fur Gastroenterologie.

Therapeutic Possibilities with DBE: A Focus on Accessories

E. Stange, C. Schäfer, 2008 .

Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate*

Robert J. Linhardt, Fuming Zhang, Thomas F. Baumert, 2003, Journal of Biological Chemistry.

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ.

R. Paus, T. Bíró, C. Schäfer, 2013, The Journal of allergy and clinical immunology.

Chronic Heavy Alcohol Use is Associated with Upregulated Paneth Cell Antimicrobials in Gastric Mucosa

G. Ott, J. Wehkamp, E. Stange, 2015, Clinical and Translational Gastroenterology.

Is nutrient intake a gender-specific cause for enhanced susceptibility to alcohol-induced liver disease in women?

C. Bode, A. Parlesak, C. Schäfer, 2007, Alcohol and alcoholism.

Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease.

C. Bode, A. Parlesak, C. Schäfer, 2002, Alcohol and alcoholism.

Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease.

C. Bode, J. Bode, B. Greiner, 1997, Journal of hepatology.

Phagocytosis and production of reactive oxygen species by peripheral blood phagocytes in patients with different stages of alcohol-induced liver disease: effect of acute exposure to low ethanol concentrations.

C. Bode, A. Parlesak, J. Diedrich, 2003, Alcoholism, clinical and experimental research.

Danish University Colleges A low concentration of ethanol reduces the chemiluminescence of human granulocytes and monocytes but not the tumor necrosis factor alpha production by monocytes after endotoxin stimulation Parlesak,

C. Bode, C. Schäfer, J. Diedrich, 1998 .

Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men

C. Bode, A. Parlesak, K. Winkler, 2014, Journal of clinical biochemistry and nutrition.

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers Published, JLR Papers in Press, April 12, 2007.

W. März, C. Bode, A. Parlesak, 2007, Journal of Lipid Research.

Intestinal absorption, metabolism, and excretion of (-)-epicatechin in healthy humans assessed by using an intestinal perfusion technique.

U. Hofmann, M. Eichelbaum, G. Williamson, 2013, The American journal of clinical nutrition.

Disposition and first‐pass metabolism of ethanol in humans: Is it gastric or hepatic and does it depend on gender?

U Klotz, U. Hofmann, U. Klotz, 1996, Clinical pharmacology and therapeutics.

Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans.

U. Hofmann, M. Eichelbaum, G. Williamson, 2015, Molecular nutrition & food research.

Antimicrobial host defense in the upper gastrointestinal tract

Guoxing Wang, S. Nuding, J. Wehkamp, 2008, European journal of gastroenterology & hepatology.

Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.

C. Bode, J. Bode, C. Schäfer, 1995, Zeitschrift fur Gastroenterologie.

First-pass metabolism of ethanol in human beings: effect of intravenous infusion of fructose.

C. Bode, A. Parlesak, H. Wehner, 2004, Alcohol.

Unchanged serum levels of advanced glycation endproducts in patients with liver disease

U. Klotz, D. Alscher, T. Niwa, 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.

C. Bode, H. Fukui, J. Bode, 1997, Alcoholism, clinical and experimental research.

C. Bode, A. Parlesak, C. Schütt, 2002, Alcohol and alcoholism.

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ.

R. Paus, T. Bíró, N. Zákány, 2013, The Journal of allergy and clinical immunology.